2-178553688-T-A
Variant summary
The NM_001267550.2(TTN):c.89317A>T (p.Ile29773Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene TTN is a known oncogene (CancerMine: 4 oncogene, 1 driver citations). The gene TTN is a cancer driver gene (CancerMine: 4 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00189 (AC=3,049) in the gnomAD database across 1,613,872 control chromosomes, including 47 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.0334. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathy 1GInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- myopathy, myofibrillar, 9, with early respiratory failureInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
- early-onset myopathy with fatal cardiomyopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- TTN-related myopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- tibial muscular dystrophyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2JInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- TTN-related myopathy, dominant-negative TTNsvInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, G2P
- congenital myopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- familial hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: G2P
- hereditary skeletal muscle disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathy 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.0334 — exceeds 1% threshold (B1 applied) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TTN | MANE Select | c.89317A>T p.Ile29773Leu | missense | Exon 334 of 363 | Prot: NP_001254479.2 UniProt: | |
TTN | c.84394A>T p.Ile28132Leu | missense | Exon 284 of 313 | Prot: NP_001243779.1 UniProt: | ||
TTN | c.81613A>T p.Ile27205Leu | missense | Exon 283 of 312 | Prot: NP_596869.4 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TTN | TSL:5MANE Select | c.89317A>T p.Ile29773Leu | missense | Exon 334 of 363 | Prot: ENSP00000467141.1 UniProt: | |
TTN | TSL:1 | c.89161A>T p.Ile29721Leu | missense | Exon 332 of 361 | Prot: ENSP00000408004.2 UniProt: | |
TTN | TSL:1 | c.89041A>T p.Ile29681Leu | missense | Exon 332 of 361 | Prot: ENSP00000405517.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0101 | AC:1538 | Hom:21 | AN:152186 | Cov:33 |
GnomAD2 exomes | AF: 0.00253 | AC:629 | AN:248516 | ||
GnomAD4 exome | AF: 0.00103 | AC:1512 | Hom:27 | AN:1461568 | Cov:33 |
GnomAD4 genome | AF: 0.0101 | AC:1537 | Hom:20 | AN:152304 | Cov:33 |
TOPMed (Bravo) | AF: 0.0119 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00216 | AC:252 | Hom:5 | AN:116576 | |
Local & regional cohorts 6 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.00769 | AC:18 | Hom:0 | AN:2342 | |
ESP6500 (Exome Variant Server) | AF: 0.0104 | AC:129 | AN:12372 | ||
GenomeAsia100K | AF: 0.00173 | AC:6 | AN:3478 | ||
Qatari Genome | AF: 0.0170 | AC:3 | AN:176 | ||
Turkish Variome | AF: 0.000177 | AC:1 | Hom:0 | AN:5174 | |
UK10K | AF: 0.000132 | AC:1 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000104 * | 1 | 9622 | 0.00 * | 0 | 10426 |
BipEx | 0.0000352 | 1 | 28418 | 0.000104 | 3 | 28828 |
Epi25 | 0.00307 | 129 | 41956 | 0.00344 | 230 | 66876 |
SCHEMA | 0.00949 | 1158 | 121994 | 0.0104 | 1983 | 191254 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 19 | |
AlphaMissense | Benign | 0.077 | |
BayesDel_addAF | Benign | -0.44 | T |
BayesDel_noAF | Benign | -0.39 | |
CADD | Benign | 17 | |
DANN | Benign | 0.69 | |
Eigen | Benign | -0.25 | |
Eigen_PC | Benign | -0.057 | |
FATHMM_MKL | Uncertain | 0.88 | D |
FuncVEP CTI | Benign | 0.00049 | |
GPN-Star LLR | N/A | -3.9 | |
GPN-Star score | N/A | 3.9 | |
LIST_S2 | Benign | 0.63 | T |
MetaRNN | Benign | 0.0049 | T |
MetaSVM | Benign | -1.1 | T |
Mutation Taster | N/A | 91/9 | polymorphism |
MutationAssessor | Benign | 0.32 | N |
PhyloP100 | Benign | 2.7 | |
PrimateAI | Benign | 0.42 | T |
PROVEAN | Benign | 0.39 | N |
REVEL | Benign | 0.076 | |
Sift | Benign | 0.71 | T |
VESM-3B | Benign | -3.6 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.